<SEC-DOCUMENT>0001144204-17-034456.txt : 20170627
<SEC-HEADER>0001144204-17-034456.hdr.sgml : 20170627
<ACCEPTANCE-DATETIME>20170627172404
ACCESSION NUMBER:		0001144204-17-034456
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170621
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170627
DATE AS OF CHANGE:		20170627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRANSGENOMIC INC
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		17933188

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		4027385480

	MAIL ADDRESS:	
		STREET 1:		12325 EMMET STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v469847_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
June 27, 2017 (June 21, 2017)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Transgenomic, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 32%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 32%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-36439</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 32%; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>91-1789357</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Incorporation)</P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>8813 F Street, Omaha NE, 68127</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(402) 452-5400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name, or Former Address, if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act
of 1934 (17 CFR 240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                            1.01</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entry
into a Material Definitive Agreement.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">As previously
disclosed on January 6, 2017, Transgenomic, Inc. (the &ldquo;Company&rdquo;) previously entered into a series of Unsecured Convertible
Promissory Notes with seven accredited investors (the &ldquo;Investors&rdquo;) in the principal amount of $925,000 (the &ldquo;Notes&rdquo;).
Pursuant to the terms of the Notes, interest accrues at a rate of 6% per year and is due and payable by the Company on December
31, 2016 (the &ldquo;Maturity Date&rdquo;). The Company also issued, to its placement agent for the Notes, a convertible promissory
note, upon the same terms and conditions as the Notes, in an aggregate principal amount equal to 5% of the proceeds received by
the Company, or $46,250 (the &ldquo;Agent Note&rdquo;). The Notes are convertible into shares of the Company&rsquo;s common stock
at the option of the Investors and as of December 31, 2016, $400,000 of the aggregate principal amount of the Notes, and accrued
interest thereon, has been converted into an aggregate of 281,023 shares of the Company&rsquo;s common stock. On the Maturity Date,
the then outstanding aggregate amount owed on the Notes and Agent Note of $638,016 ($571,250 in principal amount and $66,766 of
accrued interest) became due. Pursuant to the terms of the Notes, the Company&rsquo;s failure to pay any principal or interest
within 10 days of the date such payment is due will constitute an event of default (the &ldquo;Original Prospective Event of Default&rdquo;).
On January 10, 2017, the Investors executed a waiver of the Original Prospective Event of Default, pursuant to which, the Investors
agreed to waive the Original Prospective Event of Default on the condition that the Company and the Investors enter into definitive
documentation evidencing the terms for an extended Maturity Date of the Notes and the Agent Note on or before January 16, 2017
(the &ldquo;Waiver Deadline&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">As previously
disclosed on January 17, 2017, on January 13, 2017, all but one Investor exercised their conversion rights relating to their respective
Notes, including the Agent Note, and agreed to convert an aggregate amount of $499,359 of principal and interest due under the
Notes and Agent Note into 416,133 shares of the Company&rsquo;s common stock. The Waiver Deadline has been extended with respect
to the remaining Investor who has not exercised conversion rights (the &ldquo;Non-Converting Investor&rdquo;) so that the parties
can continue to discuss a resolution of the Original Prospective Event of Default relating to such Non-Converting Investor&rsquo;s
Note with an outstanding amount due of $139,876 as of January 13, 2017 ($125,000 in principal amount and $14,876 of accrued interest).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">As previously
disclosed on January 20, 2017, on January 17, 2017, the Non-Converting Investor agreed to extend the Maturity Date of its Note
pursuant to an amendment to the Note (the &ldquo;Amendment&rdquo;). The Amendment provides that two-thirds of the outstanding principal
amount of the Note must be paid upon the earlier to occur of the close of the Company&rsquo;s merger with Precipio Diagnostics,
LLC or June 16, 2017 (such applicable date, the &ldquo;Original Deferred Maturity Date&rdquo;). The remaining one-third of the
principal amount outstanding on the Note must be paid on the six month anniversary of the Original Deferred Maturity Date (the
&ldquo;Original Extended Maturity Date&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">On the applicable
Original Deferred Maturity Date, all accrued and unpaid interest on the Note as of the Original Deferred Maturity Date will be
converted into shares of the Company&rsquo;s common stock at a conversion price based on the average closing price of Company common
stock on The NASDAQ Stock Market LLC (&ldquo;NASDAQ&rdquo;) for the 20 consecutive trading days immediately preceding the date
of conversion, but in no event will the conversion price be less than $0.25 per share. Interest that accrues on the remaining principal
amount of the Note from the Original Deferred Maturity Date will be payable on the Original Extended Maturity Date, unless the
Note is converted in which case such interest will be payable in shares of the Company&rsquo;s common stock as part of the conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">In exchange for
extending the Original Maturity Date of the Note, the Company agreed to issue to the Non-Converting Investor on the applicable
Original Deferred Maturity Date a warrant to purchase shares of the Company&rsquo;s common stock having an aggregate value of $6,250
with an exercise price to be determined as of the date of issuance of the warrant based on the average closing price of Company
common stock on NASDAQ for the 20 consecutive trading days immediately preceding the date of issuance of the warrant, subject to
the approval of NASDAQ if necessary. The warrant will expire two years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">On the Original
Deferred Maturity Date, the then outstanding aggregate amount owed on the Notes of $143,041.10 <B>(</B>$125,000 in principal amount
and $18,041.10 of accrued interest) became due. Pursuant to the terms of the Notes, the Company&rsquo;s failure to pay any principal
or interest within 10 days of the date such payment is due will constitute an event of default (the &ldquo;Prospective Event of
Default&rdquo;). On June 21, 2017, the Non-Converting Investor agreed to waive the Prospective Event of Default and agreed to
further extend the Maturity Date of its Note pursuant to a side letter to the Note (the &ldquo;Side Letter&rdquo;). The Side Letter
provides that two-thirds of the outstanding principal amount of the Note must be paid upon the earlier to occur of (1) the closing
of a public offering by the Company of either common stock, convertible preferred stock or convertible preferred notes or (2)
August 16, 2017 (such applicable date, the &ldquo;Deferred Maturity Date&rdquo;). The remaining one-third of the principal amount
outstanding on the Note must be paid on the six month anniversary of the Deferred Maturity Date (the &ldquo;Extended Maturity
Date&rdquo;). All accrued and unpaid interest on the outstanding principal amount of the Note will be due and immediately payable
on the Extended Maturity Date, unless the Note is converted in which case such interest will be payable in shares of the Company&rsquo;s
common stock as part of the conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">The foregoing
description is qualified by reference to the full text of the June 21, 2017 Side Letter, which is filed as Exhibit 10.1 to this
Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 2.04.</B></TD><TD STYLE="text-align: justify"><B>Triggering Events that Accelerate or Increase a Direct
Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The information in Item 1.01 of this
Current Report is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 3.02.</B></TD><TD STYLE="text-align: justify"><B>Unregistered Sales of Equity Securities.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The information in Item 1.01 of this
Current Report is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Certain statements in this Current
Report on Form 8-K constitute &ldquo;forward-looking statements&rdquo; of the Company within the meaning of the Private Securities
Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results
to be materially different from any future results, performance or achievements expressed or implied by such statements. The known
risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in the Company&rsquo;s
filings with the SEC, including in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2016, filed with
the SEC on April 13, 2017, and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, filed with the SEC on May
18, 2017. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially
from those referred to in such statements. Accordingly, the Company claims the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this Current
Report on Form 8-K. All information in this Current Report on Form 8-K is as of the date of this report and the Company does not
undertake any duty to update this information, including any forward-looking statements, unless required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 9.01.</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Exhibits:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: left">Side Letter to extend Maturity Date of Unsecured Convertible Promissory Note by and among Transgenomic, Inc. and MAZ Partners
LP, dated as of June 21, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transgenomic, Inc. </B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 27, 2017</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Paul Kinnon</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Kinnon</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD COLSPAN="3" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 12%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="width: 38%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD>
    <TD STYLE="width: 50%; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: center"><B>Exhibit</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: center"><B><U>Number</U></B></P></TD>
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Description</U></B></FONT></TD>
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Side Letter to extend Maturity Date of Unsecured Convertible Promissory Note by and among Transgenomic, Inc. and MAZ Partners LP, dated as of June 21, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 1.5pt; padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v469847_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Courier; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="https:||www.sec.gov|Archives|edgar|data|1043961|000114420416079596|tlogo.jpg" STYLE="height: 63px; width: 229px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">June 21, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MAZ Partners LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1130 Route 46, Suite 22</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Parsippany, New Jersey 07054</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Walter Schenker</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Re:</B></TD><TD STYLE="text-align: justify">Side Letter to extend Maturity Date of Unsecured Convertible
Promissory Note</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To MAZ Partners LP:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reference is made to that certain First
Amendment to Unsecured Convertible Promissory Note (the &ldquo;<U>Note Amendment</U>&rdquo;) dated as of January 17, 2017, by and
among Transgenomic, Inc. (the &ldquo;<U>Company</U>&rdquo;) and MAZ Partners LP (&ldquo;<U>MAZ</U>&rdquo;) which, among other things,
extended the original Maturity Date of the Unsecured Convertible Promissory Note (the &ldquo;<U>Note</U>&rdquo;) issued by the
Company to MAZ on January 20, 2015. All capitalized terms used herein, but not specifically defined herein, shall have the meanings
provided for such terms in the Note Amendment and the Note, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Section 1(a) of the Note Amendment,
two-thirds of the outstanding principal amount of the Note became due and payable on June 16, 2017 (the &ldquo;<U>Original Deferred
Maturity Date</U>&rdquo;). The Company failed to pay the amount due on the Note on the Original Deferred Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 4 of the Note provides that if
the Company fails to make any payment (whether principal, interest or otherwise) under the Note within 10 days of when such payment
is due, such failure to pay would constitute an Event of Default thereunder (the &ldquo;<U>Prospective Event of Default</U>&rdquo;).
MAZ hereby waives the Prospective Event of Default and agrees that the Company&rsquo;s failure to make the required payments under
the Note as described above and in accordance with Section 1(a) of the Note Amendment on the Original Deferred Maturity Date shall
not constitute an Event of Default under the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MAZ and the Company agree, effective as
of the date hereof, that Sections 2(a) and 2(b) of the Note shall be amended and restated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;2.&#9;<B>PAYMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&ldquo;(a) &#9;<B>Principal</B>. If not otherwise repaid
pursuant to Section 2(e) below or converted pursuant to Section 3 below, (i) two-thirds of the outstanding principal amount of
this Note shall be due and payable on the first to occur of (1) the closing of a public offering by the Company of either common
stock, convertible preferred stock or convertible preferred notes or (2) August 16, 2017 (such applicable date, the &ldquo;<B>Deferred
Maturity Date</B>&rdquo;) and (ii) the remaining one-third of the outstanding principal amount of this Note shall be due and payable
on the sixth month anniversary of the Deferred Maturity Date (the &ldquo;<B>Extended Maturity Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 21, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(b)&nbsp;&nbsp;&nbsp;<B>Interest</B>.
All accrued and unpaid interest on the outstanding principal amount of this Note shall be due and immediately payable on the first
to occur of (1) the Extended Maturity Date or (2) upon the conversion of this Note in accordance with the terms of Section 3 below,
in which case such interest shall be payable solely in shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This letter shall not be deemed to waive
any other covenant or any other provisions of the Note or any other non-compliance by the Company with the Note, whether or not
the events, facts or circumstances giving rise to such non-compliance existed on or prior to the date hereof. Except as expressly
modified by this letter, the Note shall remain in full force and effect pursuant to its terms. The Company hereby ratifies and
reaffirms its indebtedness, duties and obligations under the Note, as modified or amended by this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This letter shall be enforced, governed
and construed in all respects in accordance with the laws of the State of New York, as such laws are applied by the New York courts
to agreements entered into and to be performed in New York by and between residents of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<I>Signature pages follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 21, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 16%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Transgenomic, Inc.</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Paul Kinnon</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Kinnon</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ACCEPTED AND AGREED TO:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MAZ Partners LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Walter Schneker</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Walter Schneker</FONT></TD>
    <TD STYLE="width: 61%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  _ .4# 2(  A$! Q$!_\0
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(R5>_]?<?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
